National heart foundation of Australia consensus statement on catheter ablation as a therapy for atrial fibrillation

Medical Journal of Australia

Volumn 198, Issue 1, 2013, Pages 518-521

  Kalman, Jonathan M ^a   Sanders, Prashanthan ^b   Brieger, David B ^c   Aggarwal, Anu ^a   Zwar, Nick A ^d   Tatoulis, James ^e   Tay, Andre E ^f   Wilson, Alison ^e   Branagan, Maree G ^e  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c Department of Geriatric Medicine   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e NATIONAL HEART FOUNDATION OF AUSTRALIA   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; WARFARIN;

AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ARTICLE; ASYMPTOMATIC DISEASE; ATRIOESOPHAGEAL FISTULA; AUSTRALIA; CARDIOVERSION; CATHETER ABLATION; CHADS2 SCORE; CONSENSUS DEVELOPMENT; DISEASE DURATION; ESOPHAGUS FISTULA; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART SIZE; HEART TAMPONADE; HEMATOMA; HOSPITALIZATION; HUMAN; LONG TERM CARE; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NERVE INJURY; PATIENT MONITORING; PATIENT SAFETY; PATIENT SELECTION; PREVALENCE; PULMONARY VEIN ISOLATION; PULMONARY VEIN OBSTRUCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; THROMBOEMBOLISM; TREATMENT DURATION; TREATMENT INDICATION; VALVULAR HEART DISEASE; CONFERENCE PAPER; INSTRUMENTATION; METHODOLOGY; PRACTICE GUIDELINE; RECURRENT DISEASE; TREATMENT OUTCOME;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; AUSTRALIA; CATHETER ABLATION; HUMANS; RECURRENCE; SOCIETIES, MEDICAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84874643177     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja12.10929     Document Type: Article

References (22)

1. Camm AJ, Kirchhof P, Lip GY, et al; European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
2. PricewaterhouseCoopers.The economic costs of atrial fibrillation in Australia. June 2010. http://www.strokefoundation.com.au/index2.php?option=com_ docman&task=doc_view&gid=318&Itemid=39 (accessed Oct 2012).
3. Wong CX, Brooks AG, Leong DP, et al. The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia. Arch Intern Med 2012; 172: 739-741.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
5. National Health and Medical Research Council. NHMRC levels of evidence and grades for recommendations for developers of clinical practice guidelines. Canberra: NHMRC, 2009. http://www.nhmrc.gov.au/guidelines/resourcesguideline- developers (accessed Aug 2012).
6. Calkins H, Brugada J, Packer DL, et al; European Heart Rhythm Association (EHRA); European Cardiac Arrhythmia Scoiety (ECAS); American College of Cardiology (ACC); American Heart Association (AHA); Society of Thoracic Surgeons (STS). HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007; 4: 816-861.
7. Oral H, Chugh A, Ozaydin M, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765.
8. Themistoclakis S, Corrado A, Marchlinski FE, et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 2010; 55: 735-743.
9. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.
10. Haïssaguerre M, Shah D, Jaïs P, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102: 2463-2465.
11. Brooks AG, Stiles MK, Laborderie J, et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm 2010; 7: 835-846.
12. Brooks AG, Wilson L, Kuklik P, et al. Image integration using NavX Fusion: initial experience and validation. Heart Rhythm 2008; 5: 526-535.
13. Natale A, Raviele A, Arentz T, et al. Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 2007; 18: 560-580.
14. Kobza R, Hindricks G, Tanner H, et al. Late recurrent arrhythmias after ablation of atrial fibrillation: incidence, mechanisms, and treatment. Heart Rhythm 2004; 1: 676-683.
15. Jaïs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008; 118: 2498-2505.
16. Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006; 48: 2340-2347.
17. Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634-2640.
18. Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010; 303: 333-340.
19. Medi C, Sparks PB, Morton JB, et al. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up. J Cardiovasc Electrophysiol 2011; 22: 137-141.
20. Ouyang F, Tilz R, Chun J, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 2010; 122: 2368-2377.
21. Weerasooriya R, Khairy P, Litalien J, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011; 57: 160-166.
22. Lee G, Sparks PB, Morton JB, et al. Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. J Cardiovasc Electrophysiol 2011; 22: 163-168.